The Supreme Court heard the case on the legality of FDA regulation of Mifepristone. Issues of standing seemed to dominate, so Professor Amar treats us to a master class on standing - in this case, and its recent evolution. He also suggests that at least one Justice might benefit by attending. In a wide-ranging episode, we also share excitement and some new scholarly insights that emerged from the recent EverScholar program led by Akhil and others; and the Trump gag order gives rise to some musings as well. There’s a lot for everyone in this episode, including CLE available from podcast.njsba.com.
Sense and Nonsense on Immunity
Don't Touch but Do Convict
Crime Means Punishment
Immunity Therapy
History Will Judge
Dissenting in Concurrence
What the Concurrences Should Have Said
Happy Anniversary Mr. Lincoln from the Court
Staking our Claim
What the Oral Argument Should Have Said - Part 2
What the Oral Argument Should Have Said
20 Questions on Section 3 and Insurrection #1 - Special Guest Ted Widmer
A Self-Educating Gaffe
The Amicus Brief - Part Two
Friends of the Court - The Brief
Section Three Goes to Washington
Section Three Punditry: The Good, The Bad, and The Silly
The World Turns to Section Three
Juries, Jarkesy, and a Joke
Create your
podcast in
minutes
It is Free